To THE MEMBERS OF BODAL CHEMICALS LIMITED,
The Directors hereby present their "38th ANNUAL
REPORT" on the performance of the Company together with the audited financial
statements for the financial year ('FY") ended March 31, 2024.
FINANCIAL RESULTS:
Financial Results of the Company for the year under review along with
figures of the previous year are as follows:
Particulars (Rs in Mn) |
Consolidated |
Standalone |
|
FY24 |
FY23 |
Y-o-Y |
FY24 |
FY23 |
Y-o-Y |
Revenue from Operation |
13,946.2 |
15,742.8 |
|
13864.4 |
15,551.2 |
|
Other Income |
248.0 |
116.1 |
|
154.3 |
79.8 |
|
Total Revenue |
14,194.2 |
15,858.9 |
-10.5% |
14,018.7 |
15,631.0 |
-10.3% |
Raw Material Consumed |
6,994.9 |
8,953.9 |
|
7,021.5 |
8,911.0 |
|
Employee Expenses |
1,027.6 |
948.1 |
|
985.1 |
918.8 |
|
Other Expenses |
4,816.8 |
4,507.5 |
|
4,779.1 |
4,510.1 |
|
Loss relating to Company's subsidiaries operating in
hyperinflationary economy |
160.1 |
- |
|
- |
- |
|
EBITDA |
1,194.7 |
1,449.5 |
-17.6% |
1,233.0 |
1,291.2 |
-4.5% |
EBITDA (%) |
8.4% |
9.1% |
|
8.8% |
8.3% |
|
Depreciation |
604.9 |
530.9 |
|
595.8 |
521.6 |
|
EBIT |
589.8 |
918.6 |
|
637.2 |
769.6 |
|
EBIT (%) |
4.2% |
5.8% |
|
4.5% |
4.9% |
|
Finance Cost |
542.5 |
410.3 |
|
518.8 |
344.1 |
|
Profit Before Tax |
47.3 |
508.4 |
|
118.4 |
425.5 |
|
Tax |
-17.4 |
128.03 |
|
41.0 |
114.08 |
|
Profit After Tax |
64.7 |
380.3 |
-83.0% |
77.4 |
311.4 |
-75.2% |
Profit After Tax (%) |
0.5% |
2.4% |
|
0.6% |
2.0% |
|
EPS (in ') |
0.5 |
3.0 |
|
0.6 |
2.5 |
|
Note: Previous year's figures have been recast wherever necessary.
The Financial year under review 2023-24 PERFORMANCE DISCUSSSION
FY24 |
' 14194mn Revenue |
' 1195mn EBITDA |
' 65mn PAT |
(On Consolidated basis)
Factors that leading to performance of the Company in FY 23-24:
- During the year, Sale Revenue from Dye Intermediates was ' 4,524 mn,
15% improvement on YOY basis. Revenue from Dyestuffs during FY24 was 4,705 mn, 13%
degrowth on YOY basis. Revenue from Basic Chemicals during FY24 was ' 1,214 mn, degrowth
of 30%.
- During the year, Chlor Alkali business has reported de-growth in
revenue as well as steep decline in margin due to adverse market condition of
Caustic-Chlorine industry. In FY24, post up-gradation capex, despite of growth in volume
by 17%, due to a substantial price reduction, Chlor Alkali revenue stood at 2,685 mn, a de
growth of 18% on YoY basis.
Bodal Chemicals Limited (BCL)
Bodal Chemicals Limited is a Integrated and Innovative company,
offering end-to-end solution to our customers globally. Company is among world's largest
manufacturer and exporter of Dyes Intermediate, Dyestuff and Sulphuric Acid, with
vertically and horizontally integrated who provides product solutions and service solution
on fastest possible route to their customers.
Bodal Chemicals Limited having its presence not only in India but
across the Globe and serving to 35+ countries with its Innovative products and services.
It is coupled with company's technical know- how, & expertise in manufacturing of
Dyestuff, Dyes Intermediate & other Specialty Chemicals. Company's growth is propelled
with the support of team members and management professionals, who work diligently to take
the organization to newer heights year-on-year.
Company's Manufacturing Facilities:
BCL has its manufacturing units across India, where Company
manufactures different products. At present Company have total 7 (Seven) Manufacturing
units in operation:
- Vadodara-3,
- Saykha-1
- Kambhat-1,
- SPS Unit (Kosi)-1
- Punjab-1.
All plants are Environment Complaint.
Company's' Manufacturing units produces different specialty chemicals
and products for Textile, Paper, Plastic, Leather, Water purification and many other.
Further, during the year, your company has decided to permanently stop
production activities at the manufacturing facilities of Unit-1, Unit-3 and Unit-4 located
at Vatva GIDC, Ahmedabad, Gujarat. The company has manufacturing facilities of Dye
Intermediate and Dyestuffs at Unit - 1, Dye Intermediate at Unit - 3 and Dyestuffs at Unit
- 4 respectively. These are small and very old plants constructed between 1989 to 1993.
Due to technological changes these plants are no longer economically viable. Operating
capacity has been very low at these plants for the last several years. Further, the
Company has already increased capacity by doing debottlenecking for Dye Intermediate at
UNIT 6 and UNIT 7. Hence, it will not result in any major production loss for the company.
Overall efficiency will improve due to the reduction of fixed overheads.
Furthermore, Company will dismantle said manufacturing facilities and
it will lead to reduction of less than 3% in the total tonnage production capacity of the
company.
Company's Saykha Greenfield Project has commenced its commercial
operation of Benzene Downstream products on 29th December 2023 by starting
production of MCB. also Company has started production of other products i.e. PNCB and
ONCB on 16th March, 2024. These specialty products are expected to stabilized
by Q2FY25.
BCL has its inhouse R&D Lab:
-1- Ahmedabad-Gujarat -2- Vadodara- Gujarat
Company's Operation are Covered:
- Dyestuff
- Dye Intermediates
- Bulk Chemicals
- Sulphuric Acid and its derivates.
- Chlor Alkali
- TCCA- Water Purification
- Benzene Derivative (MCB, PNCB, ONCB)
- Thionyl Chloride (TC)
Company's 11 Depots: (Exclusive Distribution Warehouse)
-7- India -1- China -1- Turkey -1- Bangladesh -1-Indonesia
Bodal Chemicals Limited is listed:- ISIN: INE338D01028
-BSE Ltd. (Bombay Stock Exchange) Code: 524370
-National Stock Exchange of India Ltd. (NSE) Code: BODALCHEM
BODAL CHEMICALS LIMITED
Subsidiary in India |
Subsidiaries Outside India |
1 Bodal Chemicals Trading Pvt Ltd 100% Stake |
1 Bodal Chemicals Trading (Shijiazhuang) Co., Ltd. 100% Stake |
|
2 SENER BOYA KIMYA TEKSTIL SANAYI VE TICARETANONIM SIRKETI
100% Stake |
|
3 Bodal Bangla Ltd 100% Stake |
|
4 PT Bodal Chemicals INDONESIA 100% Stake |
Associate Company |
Step-down subsidiary: |
1 Plutoeco Enviro Association 25% Stake |
1 SENPA DIS TICARET ANONIM SIRKETI |
FINANCIAL PERFORMANCE OF SUBSIDIARIES:
Particulars (Rs in mn.) |
BCTPL |
Sener Boya |
Bodal-China |
Bodal-Indonesia |
Bodal Bangla |
|
FY23 |
FY24 |
FY23 |
FY24 |
FY23 |
FY24 |
FY23 |
FY24 |
FY23 |
FY24 |
Sales |
0.01 |
0.00 |
622.8 |
283.9 |
292.7 |
299.1 |
19.9 |
45.6 |
|
--- |
PBT |
(0.63) |
(0.68) |
78.3 |
(79.9) |
13.0 |
13.8 |
(5.0) |
(0.4) |
(2.36) |
(0.51) |
PAT |
(0.47) |
(0.51) |
66.4 |
(20.0) |
12.9 |
13.7 |
(5.0) |
(0.4) |
(2.36) |
(0.70) |
BODAL CHEMICALS TRADING PVT LTD
Bodal Chemicals Trading Pvt Ltd, a Wholly Owned Subsidiary Company was
incorporated in India on 07th December 2018. It was incorporated with object of
trading in chemical products. The Company has Commenced commercial operations. It is not
material subsidiary as per the SEBI (Listing Obligations and Disclosures Requirements)
Regulations, 2015
Further, Financial Results of the Company for FY 2023-24 are available
on website of the Company at www.bodal.com
BODAL CHEMICALS TRADING SHIJIAZHUANG LTD (CHINA)
Bodal Chemicals trading Shijiazhuang Ltd, a Foreign Wholly Owned
Subsidiary of the Company incorporated in China in FY 2018-19, for trading activities in
Chemical Products.
Apart from the trading activity within China, this company will become
an important arm for bodal chemicals Ltd to distribute its final product i.e. dyestuffs in
domestic market of China. This will also help sourcing of some raw materials from China to
India. The Company has started commercial operations. It is not material subsidiary as per
the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015
Further Financial Results of the Company for FY2023-24 are available on
website of the Company at www.Bodal.com
SENER BOYA KIMYA TEKSTIL SANAYI VE TICARETANONIM SIRKETI
SENER BOYA KIMYA TEKSTIL SANAYI VE TICARETANONIM SIRKETI is a Foreign
wholly owned Subsidiary company of Bodal Chemicals Limited. Apart from the trading
activity within Turkey, this company will become an important arm for Bodal Chemicals Ltd
to distribute its final product i.e. dyestuffs in domestic market of Turkey and reach out
to other Local Areas. It is not material subsidiary as per the SEBI (Listing Obligations
and Disclosures Requirements) Regulations, 2015.
Looking at the Business Growth perspective, Your Company had acquired
remaining 20% Stake of SENER BOYA- from existing Shareholders of the Company and SENER-
Turkey has become Wholly Owned Subsidiary Company of Bodal Chemicals Ltd w.e.f. 28th
March 2022 by owing 100% Equity Stake.
Relevant Disclosures Under Regulation 30 of SEBI (Listing Obligation
and Disclosure Requirement) Regulations, 2015 were also intimated to Stock Exchanges (BSE
& NSE) along with required information.
Further Financial Results of the Company for FY2023-24 are available on
website of the Company at www.Bodal.com
BODAL BANGLA LTD
Bodal Bangla Ltd, a Foreign Wholly Owned Subsidiary of the Company
incorporated on 22nd September 2019 in Bangladesh, for trading activities in
Chemicals Products. The Company has started Commercial Operations. Further It is not
Material Subsidiary as per the SEBI (Listing Obligations and Disclosures Requirements)
Regulations, 2015
Further, Financial Results of the Company are available on website of
the Company at www.bodal.com
PLUTOECO ENVIRO ASSOCIATION
Plutoeco Enviro Association, a Associate Company of the Company
incorporated on 27th October 2020 as Section 8 Company for working as
Non-Profit Organization.
Further, Financial Results of the Company are available on website of
the Company at www.bodal.com
SENPA DIS TICARET ANONIM SIRKETI
SENPA DIS TICARET ANONIM SIRKETI is a Step-Down Subsidiary company of
Bodal Chemicals Limited. SENPA DIS TICARET ANONIM SIRKETI is Wholly Owned Subsidiary of
SENER BOYA KIMYA TEKSTIL SANAYI VE TICARETANONIM SIRKETI which is subsidiary company of
Bodal Chemicals Ltd incorporated in FY 2018-19 in Turkey.
PT BODAL CHEMICALS INDONESIA
Your Company has incorporated a Foreign Wholly Owned Subsidiary Company
in Indonesia namely PT Bodal chemicals Indonesia
Pursuant to the provisions of Section 129, 134 and 136 of the Companies
Act, 2013 read with rules framed there under and Regulation 33 of the SEBI Listing
Regulations, the Company has prepared consolidated financial statements of the Company and
its subsidiaries and a separate statement containing the salient features of financial
statement of subsidiaries, joint ventures and associates in Form AOC-1 which forms
part of this Annual Report. Further
Company shall place separate audited accounts of the subsidiary
Companies on the website of the Company at www.bodal.com
Pursuant to Section 134 of the Act read with Rule 8(1) of the Companies
(Accounts) Rules, 2014 the details of developments of subsidiaries of the Company are
covered in the Management's Discussion and Analysis Report which forms part of this
Report.
CAPITAL STRUCTURE & LIQUIDITY
Authorised Share Capital
During the FY 2023-24, Authorised Share Capital of the company stood at
' 71,15,00,000/- (Rupees Seventy One Crores Fifteen Lakhs Only) comprising Equity Share
Capital of ' 43,65,00,000 (Rupees Forty Three Crores Sixty Five Lakhs Only) divided into
21,82,50,000 (Twenty One Crores Eighty Two Lakhs Fifty Thousand) Equity Shares of ' 2/-
(Rupees Two) each and Preference Share Capital of ' 27,50,00,000 (Rupees Twenty Seven
Crore Fifty Lakhs only) divided into 2,75,00,000 (Two Crore Seventy Five Lakhs) Preference
Shares of ' 10/- (Rupees Ten) each.
Issued and paid-up Share Capital
The Issued, Subscribed & Paid-up Equity Share Capital of the
Company as at 31st March 2024 was ' 25,15,79,130/- (Rupees twenty five crores
fifteen lakhs seventy nine thousand one hundred thirty only) divided into 12,57,89,565
Equity Shares, having face value of ' 2 each.
During the year Under Review, the Company has allotted 1,66,100 No of
Equity shares in pursuant of Bodal ESOP Scheme 2017 to eligible employees of the Company
on 17th June 2023.
Particulars |
No of Shares |
Paid Up Capital at the Beginning of the Year (01-04-2023) |
12,56,23,465 |
Addition of Shares (Pursuant to ESOP Allotment) |
1,66,100 |
Paid Up Capital at the End of the Year (31-03-2024) |
12,57,89,565 |
Employees Stock Option (ESOP/ESOS)
- Allotment under ESOP:
During the year Under Review, NRC Committee of the Company at their
meeting held on 17th June 2023 made allotment of 1,66,100 (Grant-05) equity
shares of ' 2/- each at a premium of ' 8/- per share, pursuant to exercise of options
under the ESOP-2017 Scheme.
- Grant of Stock Options
During the year under reviews, Nomination and Remuneration Committee of
Board of Directors of the Company at its meeting held on 17th June, 2023 had
considered, approved and made grant of 1,66,100 No. of Stock Options (Grant-06) under
Bodal Chemicals Limited- ESOP 2017
Disclosure Pursuant to Regulation 30 of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015, intimated to Stock Exchanges (BSE & NSE).
Details and Summery of Employee Stock Options granted/ vested/exercised
during the year 2023-24 are given in "Annexure 2" to this report.
General Reserve
During the year under review, your directors do not propose to transfer
any amount to the General Reserve.
Term Loan and Working Capital
As on 31st March 2024, the Total Debt was ' 8,969.67
Million, cash and Cash Equivalents were ' 184.98 Million resulting in Net Debt of '
8,784.69 Million (' 7,493.68 Million as on 31st March 2023). Total Debt
consisted of ' 4,539.69 Millions of working capital loans and ' 4,429.98 Millions of
long-term loans.
RATINGS
The credit rating for the Company for last two years are as below: -
Type of Credit Rating |
Ratings as on 31-03-2024 |
Ratings as on 31-03-2023 |
|
India Ratings |
India Ratings |
Long Term Bank Facilities |
IND BBB+/ Negative |
IND A+/Negative |
Short Term Bank Facilities |
IND BBB+/ Negative/IND A2 |
IND A+/Negative /IND A1 + |
DIVIDEND
During the year under review, The Board of Directors of your Company
("Board"), After considering the relevant circumstances, current business
environment and keeping in view of Company's Dividend Distribution Policy has decided that
it would be prudent not to recommend any dividend for the year under review.
TRANSFER OF UNCLAIMED SHARES & DIVIDEND AMOUNT TO INVESTOR
EDUCATION AND PROTECTION FUND
Section 124 of the Companies Act, 2013 mandates that companies shall
transfer dividend that remain unclaimed for a period of seven years, from the unpaid
dividend account to the Investor Education and Protection Fund (IEPF).
During the year under review, Your Company has transferred 12175 No of
shares to IEPF Account for unclaimed Dividend for 7 years from the date of declaration of
Dividend for FY 2015-16 (2nd Interim Dividend).
During the year under review, Your Company has transferred 12506 No of
Shares to IEPF Account for unclaimed Dividend for 7 years from the date of Declared of
Dividend for FY 2016-17 (1st Interim Dividend).
Further, The Company has uploaded complete details of such Shares which
were already transferred to DEMAT Account of IEPF Authority on its website:- www.bodal.com
Furthermore, Shareholders may claim back the shares which were already
credited along with the unclaimed dividend amount from IEPF Authority after following the
procedures prescribed under IEPF Rules. The procedure for claiming the same is available
at www.mca. gov.in and www.iepf.gov.in.
Further, Details of IEPF Claim during the FY 2023-24 is stated in the
Corporate Governance report of the Company, which is part of this Director's Report
forming part of this Annual Report.
PUBLIC /FIXED DEPOSITS
During the year under review, The Company has not accepted any deposit.
There were no deposits remaining unpaid/ unclaimed as at the end of the financial year
2023-24 and as such no amount of principal or interest was outstanding, as on the date of
the balance sheet.
LISTING OF SECURITIES
Bodal Chemicals has 125789565 Equity Shares of ' 2 each fully paid,
listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) as on 31st
March 2024. The Company confirms that it has paid annual listing fees for the financial
year 2024-25 to both the Exchange (BSE & NSE) where the Company's equity shares are
listed.
DIRECTORS AND KEY MANAGERIAL PERSONNEL
Directors' Appointment, Retirement and Resignation
Bodal Chemicals has 8 (Eight) Directors including 4 (Four) Executives
Director and 4 (Four) Independent cum Non-Executive Director including a women director at
the end of financial year 31st March 2024.
KEY MANAGERIAL PERSONNEL
- Mr. Suresh J Patel, Chairman and Managing Director (DIN: 00007400)
- Mr. Bhavin S Patel, Executive Director (DIN:0030464)
- Mr. Ankit S Patel, Executive Director (DIN: 02173231)
- Mr. Mayur B Padhya, Chief Financial Officer
- Mr. Ashutosh B Bhatt, Company Secretary
Are the key managerial Personnel of the Company as on the date of this
Report.
DECLARATION BY INDEPENDENT DIRECTORS
The Company has received declaration from all Independent Directors
that they meet the Criteria of Independence as laid down in Section 149 (6) of the
Companies Act, 2013 and regulations 27 (2) of the SEBI (LODR) regulations, 2015 (Listing
regulations). There were no pecuniary transactions entered into with the Independent
Directors apart from sitting fees.
REMUNERATION OF DIRECTORS AND KMP
Pursuant to the provisions of Section 197(12) of the Companies Act,
2013 read with Rules 5(1), 5(2) and 5(3) of the Companies (Appointment and Remuneration of
Managerial personnel) Rules, 2014, disclosures pertaining to remuneration of Managerial
employees, a Statement showing the names and other particulars of the employees drawing
remuneration in excess of the limits set out in the said rules is attached as Annexure
3 which forms part of this Report.
Company received Confirmation from Chairman of NRC Committee of the
Company that Appointment term and Remuneration decided by the NRC Committee are based on
NRC Policy of the Company.
REMUNERATION POLICY
The Company has in place a Remuneration policy for the Directors, KMP
and Other employees pursuant to the provisions of the Act and the Listing Regulations
which is explained in Corporate Governance Report and which forms a part of the Board's
Report.
FAMILIARIZATION PROGRAMME FOR INDEPENDENT DIRECTORS:
The Company has an ongoing Programme where Directors in the course of
meetings of the Board of Directors give information about Chemical Business developments,
Expansion of the Company and various amendments in legal and regulatory areas which
include mandatory disclosures and fair disclosures stated under SEBI (Listing Obligation
and Disclosures Requirement) regulations, 2015 (herein referred to as "Listing
Agreement"), Prohibition & Insider trading regulations, and SAST Regulations so
as to enable them to effectively discharge their roles, rights and responsibilities in the
Company.
Details of the Familiarization Programme for Independent Directors are
available on the website of the Company at www.bodal.com
DIVERSITY OF THE BOARD
The Company recognizes and embraces the benefit of having a diverse
Board of Directors and views increasing diversity at the Board level as an essential
element in maintaining competitive advantage in the Business in which it operates.
BOARD MEETINGS
During the year under review, 5(Five) Board Meetings of Board of
Directors were held. Details of the Composition of Board and its Committees and meetings
held and Attendance of Directors at such Meetings and other relevant details are provide
in the Corporate Governance report, forming part of this Director's Report.
MEETING OF INDEPENDENT DIRECTORS
The Independent Directors of the Company met separately on 13th
February 2024. Meeting dated 13th February 2024 held without the presence of
Non-Independent Directors and the members of management. In accordance with the provisions
of the Companies Act, 2013 and SEBI (Listing Obligation and Disclosure Requirement)
Regulation, 2015, the following matters were, inter-alia discussed in the meeting:
> Review the performance of Non-Independent Directors and the Board
as a whole
> Review the performance of the Chairperson of the Company, taking
into account the views of Executive Directors and Non- executive Directors.
> Assess the quality, quantity and timelines of flow of information
between the Company management and the Board that is necessary for the Board Members to
effectively and reasonably perform their duties.
BOARD'S ANNUAL EVALUATION
In terms of the requirements of the Companies Act, 2013, and the
Listing Regulations, the Board carried out the annual performance evaluation of the Board
as a whole, Board Committees and the Directors. The Evaluation framework adopted by the
Board is set out in the Corporate Governance Report.
AUDITORS
STATUTORY AUDITORS
Members at its 36th Annual General Meeting held on 26th
September 2022 appointed M/s. Naresh J. Patel & Co., Chartered Accountants (Firm
Registration No.: 123227W) as Statutory Auditor of the
Company to hold office from conclusion of 36th Annual
General Meeting of the Company until the Conclusion of 41st Annual General
Meeting of the Company.
The Statutory Auditors have confirmed that they satisfy the
Independence criteria required under Companies Act 2013 Code of Ethics issued by institute
of Chartered Accounts of India.
The report of the Statutory Auditors along with Notes to Schedules is
enclosed with this Report. The Auditor's Comments on the Company's Accounts for the
financial year ended on 31st March 2024 are self-explanatory in nature and do
not require any explanation as per provisions of Section 134 of the Companies Act,
2013.The Auditor's Report does not contain any qualification, reservation or adverse
remark.
INTERNAL AUDITORS
M/s. Rashmin R. Patel & Co., Chartered Accountants (FRN: 132265W),
Ahmedabad are Internal Auditors of the Company. Internal Auditors are appointed by the
Board of Directors of the Company on a yearly basis, based on the recommendation of the
Audit Committee. The Internal Auditors report their findings on the internal audit of the
Company, to the Audit Committee on a quarterly basis. The scope of internal audit is
approved by the Audit Committee.
SECRETARIAL AUDITOR
Pursuant to Section 204 of the Companies Act, 2013 and The Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014, the Company has
appointed Mr. Tapan Shah, Practicing Company Secretary as a Secretarial Auditor to conduct
Secretarial Audit of the Company for the financial year 2023-24 (Period from 01.04.2023 to
31.03.2024).
The Report of Secretarial Auditor for the financial year 2023-24 is set
out as Annexure 4 and it forms a part of this Report.
Further, under regulation 24A of SEBI (LODR) Regulations, Company has
received Secretarial Compliance Report for the FY 23-24 from Tapan Shah, Practicing
Company Secretary and same to be filed with the Stock Exchanges (BSE & NSE).
COST AUDITORS
Pursuant to Section 148 of the Companies Act, 2013, the Central
Government has prescribed cost audit related to the Company's product Dye Intermediates
and Dyes. Based on this requirement and the recommendation made by the Audit Committee,
the Board of Directors has appointed M/s. Kiran J. Mehta & Co., Cost Accountants,
Ahmedabad, as the Cost Auditor for the Financial Year 2024-25. The Company has received a
written certificate from the Cost Auditor stating that their re-appointment, if made,
would be within the prescribed limits under sections 141 of the Companies Act, 2013. The
Cost Audit report for the FY 2023 has been filed within the prescribed time limits. The
Cost Auditor's Report does not contain any qualification, reservation or adverse remark.
Further, remuneration payable to them is required to be ratified by the Shareholders at
the ensuing Annual General Meeting and accordingly, a resolution seeking ratification has
been included in the Notice convening the Annual General Meeting.
During the year under review, the statutory auditors, secretarial
auditors and cost auditors have not reported any instances of fraud committed in the
Company by its officers or employees to the Audit Committee under section143(12) of the
Companies Act, 2013, details of which needs to be mentioned in this Report.
MANAGEMENT DISCUSSION & ANALYSIS
Pursuant to Regulation 34 of the Listing Regulations, the Management
Discussion and Analysis Report for the financial year under review is presented in
Separate Section, forming part of the Annual Report.
CORPORATE GOVERNANCE
Bodal Chemicals Ltd. is committed to ensuring the highest levels of
ethical standards, professional integrity, corporate governance and regulatory compliance.
The Company understands and respects its fiduciary duty to all stakeholders and strives to
meet their expectations. The core principles of independence, accountability,
responsibility, transparency, fair and timely disclosures serve as the basis of the
Company's approach to Corporate Governance.
Report on Corporate Governance is annexed and forms an integral part of
this Annual Report. Certificate from Mr. Tapan Shah, Company Secretary in practice,
regarding compliance of conditions of Report on Corporate Governance as stipulated in the
Listing Regulations is also appended to the Report on Corporate Governance.
SECRETARIAL STANDARDS
Secretarial Standards for the Board and General Meetings (SS-1 &
SS- 2) are applicable to the Company. The Company has complied with the provisions of both
these Secretarial Standards.
INDUSTRIAL RELATIONS & HUMAN RESOURCES
Industrial relations at all divisions of your Company have always been
cordial and continue to be so. Your directors wish to place on record their appreciation
for the co-operation received from employees at all levels.
HUMAN RESOURCES -
HEALTH, SAFETY AND ENVIRONMENT-
It has been our continuous endeavor in Bodal Chemicals Ltd to create
safe, healthy & environment friendly work practices with leadership and management
support for sustainable business growth. Risk based approach is being adopted and applied
in the manufacturing process and across the business for a safe and healthy outcome which
in a way translates into revenue and acts as a catalyst in the overall growth of the
organization. Cross functional participative approach is being practiced for engaging
different functions for deeper involvement to create a holistic EHS culture. EHS risks are
being managed to an acceptable level involving all stakeholders. Shop floor Safety hands
on briefing and training in the form of TBT (Tool Box Talks) and OJT (On Job training) to
adopt safe work practices is being actively practiced. PPE's are being provisioned to all
employees and workforce. All employees are encouraged to report near misses and all
workplace incidents are collected and evaluated by doing a root cause analysis to prevent
re occurrence. During staff interactions feedback on EHS is actively sought and
suggestions are being collected and evaluated for adoption as the case may be. Following
this approach, there is a dip in numbers which is a reflection of positive EHS change
amongst all with increased risk awareness. Regular mock exercises are being practiced at
all our plants as part of Emergency Planning, Preparedness and Response. The improvement
areas are noted and further adopted going forward to enhance efficiency and effectiveness
to deal with any incidents.
We believe in the philosophy, 'Good EHS practices' makes good business
sense & Healthy & Safe workforce is a productive workforce. We have fully equipped
OHC manned round the clock with well experienced Doctors and occupational nursing staff.
In house Ambulance is also available. Pre medical check-up, annual medical check-up and
special health awareness camps are conducted for employees. Medical Team has also
initiated "Health Gallery" and company doctor conducts regular counselling
sessions and health talks for employees.
MATERIAL CHANGES AND COMMITMENTS
There were no material changes and commitments affecting the financial
position of the Company between the end of the financial year and the date of this Report.
ANNUAL RETURN
The Annual Return of the Company as on 31st March 2024 is
available at Company's website at www.bodal.com and can be accessed at
https://www.bodal.com/files/report1722508799_66ab65ff7c97c.pdf
ENVIRONMENT PROTECTION
The Company has undertaken various environment friendly measures in its
different Units for promoting a better environment. The Company has in place adequate
pollution control equipment and all the equipment's are in operation.
GREEN INITIATIVE
The Ministry of Corporate Affairs had taken the Green Initiative in
Report on Corporate Governance by allowing paperless compliances by Companies through
electronic mode. Your Company supports the Green Initiative and has accordingly decided to
send necessary communications to its Shareholders to their respective registered E-mail
addresses.
SAFETY & WELLBEING OF WOMEN AT THE WORKPLACE
Bodal Chemicals Ltd. has taken various initiatives to ensure a safe and
healthy workplace for its women employees. The Company has zero tolerance of sexual
harassment at the work Place and is fully compliant with the prevailing laws on the
prevention of sexual harassment of women at the workplace. As per the provisions of
Sections 21 and 22 of the Sexual Harassment of Women at Workplace (Prevention, Prohibition
and Redressal) Act, 2013, the Report on the details of the number of cases filed under
sexual harassment and their disposal is as under:
SR. NO. COMPLAINTS UNDER SEXUAL HARASSMENT
(FROM 01-04-2023 TO 31-03-2024) |
STATUS |
1 Number of Complaints/Cases pending as at the beginning of
FY 23-24 i.e. 01-04-2023 |
NIL |
2 Number of Complaints/ Cases filed during the year (from
01-04-2023 to 31-03-2024) |
NIL |
3 Number of Complaints/ Cases as at the end of FY 2023-24
i.e. 31-03-2024 |
NIL |
VIGIL MECHANISM AND WHISTLEBLOWER POLICY
The provisions of Section 177(9) and (10) of the Companies Act, 2013
mandates every listed company to establish vigil mechanism for Directors and employees.
Bodal Chemicals Ltd. has adopted a Whistle Blower Policy, as part of vigil mechanism to
provide appropriate avenues to all the employees of the Company to raise their concerns
relating to fraud, malpractice or any other activity or event which is against the
interest of the Company or society as a whole. Details of complaints received and the
action taken are reviewed by the Audit Committee. No concerns or irregularities have been
reported by employees/directors till date.
The functioning of the Whistle Blower mechanism is reviewed by the
Audit Committee from time to time. None of the Company's personnel have been denied access
to the Audit Committee. The Whistle Blower policy is available on the Company's website
and its web link https://bodal.com/live.php?data=6_l2
ANNUAL ACCOUNTS OF SUBSIDIARIES COMPANIES
The Accounts of the Subsidiary Companies for the financial year ended
on 31st March 2024 will be made available to any shareholder of the Company on
request and will also be available for inspection at the registered office of the Company
during working hours till the date of the Annual General Meeting.
Statement containing salient features of financial statements of
subsidiaries and Associates pursuant to section 129 of the Companies Act, 2013 read with
Rule 5 of the Companies (Accounts)
Rules, 2014 is annexed to this Report in the prescribed Form AOC-1, as "Annexure
1"
The Audited Financial Statements of Company's subsidiaries for
financial year 2023 are available on the Company's website at www. bodal.com and the same
are also available for inspection at the Registered Office of the Company. Your Company
will also make available these documents upon request by any Member of the Company
interested in obtaining the same.
The Company has laid down policy on material subsidiaries and none of
the subsidiary is material subsidiary as per the Policy. The policy is placed on the
website of the Company and its weblink is https://bodal.com/live.php?data=6_l2
CONSERVATION OF ENERGY, RESEARCH & DEVELOPMENT (R&D),
TECHNOLOGY ABSORPTION & FOREIGN EXCHANGE EARNINGS & OUTGO
The details of energy conservation, technology absorption and foreign
exchange earnings and outgo as required under section 134(3) of the Companies Act, 2013,
read with Rule 8 of Companies (Accounts of Companies) Rules, 2014 is annexed as Annexure
5 to this Report.
RISK MANAGEMENT & INTERNAL CONTROL
The Company has a Risk Management framework to identify, evaluate
business risks and opportunities. This framework seeks to create transparency, minimize
adverse impact on the business objectives and enhance the Company's competitive advantage.
The business risk framework defines the risk management approach across the enterprise at
various levels including documentation and reporting. Further details are set out in the
Management Discussion and Analysis Report forming part of the Directors' Report.
The Company deploys robust system of internal controls commensurate to
the size of the Company and the complexities of its operations. These systems facilitate
fair presentation of its financial results in a manner that is complete and reliable,
ensure adherence to regulatory and statutory compliances, and safeguards investor interest
by ensuring the highest level of governance and consistent communication with investors.
The Internal Auditors of the Company conduct financial, compliance and
process improvement audits each year. The Audit Committee oversees the scope and evaluates
the overall results of these audits, and members of that Committee regularly attend
meetings of Board of Directors. The Audit Committee also reviews the adequacy and
effectiveness of the internal control system and invites functional Directors and senior
management personnel to provide updates on operating effectiveness and controls, from time
to time. A CEO and CFO Certificate, forming part of the Corporate Governance Report,
confirm the existence and effectiveness of internal controls and reiterate their
responsibilities to report deficiencies, if any, to the Audit Committee and rectify the
same.
CYBER SECURITY
In view of increased cyberattack scenarios, the cyber security maturity
is reviewed periodically and the processes, technology controls are being enhanced in-line
with the threat scenarios. Your Company's technology environment is enabled with real time
security monitoring with requisite controls at various layers starting from end user
machines to network, application and the data.
During the year under review, your Company did not face any incidents
or breaches or loss of data breach in cyber security.
RISK MANAGEMENT COMMITTEE
Company had constituted Risk Management Committee and said Committee
had formulated a Risk Management Policy for dealing with different kinds of risks which it
faces in day-today operations of the Company. Risk Management Policy of the Company
outlines different kinds of risks and risk mitigating measures to be adopted by the Board.
The Company has adequate internal control systems and procedures to combat risks.
Committee has define Role and Responsibilities as per SEBI (Listing Obligation and
Disclosures Requirement) Regulations. You can Access it from Website of the Company at
www.bodal.com
The management of the Company is determining various aspects so as to
be able to minimize the risk in all spheres of the Company's business from finance, human
resources to business strategy, growth and stability.
PARTICULARS OF LOANS, GUARANTEES AND INVESTMENTS
During the year, the Company had not provided any corporate guarantee
or provided any Securities on behalf of others.
Details of loans, guarantees and investments covered under the
provisions of Section 186 of the Companies Act, 2013 are given in the notes to the
financial statements.
CORPORATE SOCIAL RESPONSIBILITY (CSR)
The Company's CSR Policy primarily rests on three broad tenets viz.,
Healthcare, Education & Community welfare and the same is within the ambit of Schedule
VII of the Act.
Your Company has a strong focus on making company's CSR efforts more
systematic and strategic. Company has established procedures for planning and
implementation of major CSR activities in the areas surrounding the company's plants. Your
Company is presently focused on the following key areas of CSR:
Bodal believes in inclusive development. Our business success
interwoven with the welfare of the communities within which we operate. We believe in the
lasting positive impact and ensure that society will harvest benefits of our initiatives
for the longer time.
We believe for the nation development and growth education is the key
and it is everyone's right to get better education. So we focus more on promoting
education by supporting deserving students. Also, we drive Skill Development program,
where our employee spare time and visit nearby villages and intervene with the school
teachers and try to enhance their skill sets. This Program was undertaken digitally and
physically.
Village Development: Under this program we associate with the village
people, work with the Sarpanch and other senior members, study their issues and
requirements towards the basic village infrastructure, and work directly with them to
improve the infrastructure. It's also covers, proper clean drinking water, drainage
system, Road, etc. It's also extended to the behavioral change program for the longer
sustainability.
Encouraging Education and Empowering Children: we are associated with
NGO "Yuva Unstoppable" and provide scholarship to deserving students and
encourage them for their bright future.
Further, company continued several further initiatives under the CSR
program, directly as well as through different agencies.
Further, Your Company continued several other initiatives under the CSR
program, directly as well as through agency namely "Yuva Unstoppable" permitted
under the Act.
Detail of CSR Policy and Annual Report on CSR for FY 2023-24 is annexed
to this report as "Annexure 6" and forms part of this Report
BUSINESS RESPONSIBILITY AND SUSTAINABILITY REPORT (BRSR)
The Business Responsibility Report for the year ended 31st
March 2024 as per clause (f) of sub regulation (2) of regulation 34 of Listing Regulations
is annexed and forms part of this Annual Report.
RELATED PARTY TRANSACTIONS
All the related party transactions that were entered into during the
financial year were on an arm's length basis and were in the ordinary course of business.
There are no materially significant related party transactions made by the Company with
the Promoters, Directors, Key Managerial Personnel, or other designated persons which may
have potential conflict with the interest of the company at large.
All related party transactions are placed before the Audit Committee
and the Board for approval. The Company has developed a Related Party Transaction Policy
for the purpose of identification and monitoring of such transactions. The Related Party
Transaction policy is placed on the Company's website www.bodal.com and its web link- https://bodal.com/live.php?data=6_l2
Particulars of Contracts or arrangements with Related Parties referred
to in section 188 (1) of the Companies Act, 2013, are disclosed in Form AOC-2 as Annexure
7
SIGNIFICANT AND MATERIAL ORDERS PASSED BY THE REGULATORS OR COURTS OR
TRIBUNALS IMPACTING THE GOING CONCERN STATUS OF THE COMPANY
During the year, Company received SEBI Order, Under Section 15-I of the
SEBI Act, 1992 read with Rules 5 of the SEBI (Procedure for holding Inquiry and imposing
Penalties) Rules, 1995, in the matter of M/s. Bhageria Industries Limited, where in Bodal
is a Connected Party and for that through SEBI order dated 31st March 2023,
Penalty of ' 7 lacs was levied, which was paid by the Company as on 10th May
2023. However, No Direct case/matter has been initiated against the Bodal.
No such material Order passed by the Regulators or Courts or Tribunals
which is impacting the Going Concern Status of the Company.
INSURANCE
The Company's assets are adequately insured.
DIRECTORS' RESPONSIBILITY STATEMENT
Pursuant to Section 134 of the Companies Act, 2013, the Directors, to
the best of their knowledge and belief, confirm that:
(a) in the preparation of the annual accounts for the financial year
ended on 31st March 2024, the applicable accounting standards had been followed
along with proper explanation relating to material departures;
(b) the Directors have selected such accounting policies and applied
them consistently and made judgments and estimates that are reasonable and prudent so as
to give a true and fair view of the state of affairs of the Company at the end of the
financial year and of the profit and loss of the Company for that period;
(c) the Directors have taken proper and sufficient care for the
maintenance of adequate accounting records in accordance with the provisions of this Act
for safeguarding the assets of the Company and for preventing and detecting fraud and
other irregularities;
(d) the Directors have prepared the annual accounts for the financial
year ended on 31st March 2024 on a going concern basis;
(e) the Directors, have laid down internal financial controls to be
followed by the Company and that such internal financial controls are adequate and were
operating effectively; and
(f) the Directors have devised proper systems to ensure compliance with
provisions of all the applicable laws and that such systems were adequate and operating
effectively.
ACKNOWLEDGEMENT
Your director place on record their sincere appreciation for the
steadfast commitment and highly motivated performance by employees at all levels which was
instrumental in sustained performance of the Company. Your directors also sincerely thank
all the stakeholders, professionals, business partners, government & other statutory
bodies, banks, financial institutions, analysts and shareholders for their continued
assistance, cooperation and support.
|
For and on behalf of the Board of Directors of |
|
Bodal Chemicals Limited |
|
SURESH J. PATEL |
Date : 14-08-2024 |
Chairman & Managing Director |
Place : Ahmedabad |
(DIN: 00007400) |